AIZEZI Renaguli, TAYIR Parhat, AIKEMU Ainiwaer, APER Aishanjan, Zuliayati, LU Ming, TUERXUN Tayierjiang, UPUR Halmurat
This paper studies the inhibitive effect of the abnormal savda munziq on the transplanted EAC tumor and the protective effect of the abnormal savda munziq on 5-fluorouracil-induced toxicity. The 60 transplantated EAC tumor model mice were randomly divided into 6 groups: The normal control group, the tumor control group, the 5-fluorouracil (5-FU) group, the high dose 5-FU ASMq group, the middle dose 5-FU ASMq group, and the low dose 5-FU ASMq group. The content changes of the mouse tumor inhibition rate, the spleen index, the thymus index, and the indices of liver, mouse serum SOD, MDA, GSH-Px were observed. In the 5-FU high-dose ASMq group, the 5-FU medium-dose ASMq group, the 5-FU low-dose ASMq group and the 5-FU group, the values of the tumor inhibition rate were found to be 42.41%, 58.09%, 41.58% and 50.83%, respectively, showing that the tumor function is weakened. Compared with the model group, the thymus/body weight ratio is clearly reduced in the 5-FU medium-dose ASMq group and the 5-FU low-dose ASMq group. Compared with the 5-FU group, the spleen/body weight ratio is clearly increased in the 5-FU high-dose ASMq group, the 5-FU medium-dose ASMq group, and the 5-FU low-dose ASMq group, and the difference was significant (P<0.05). In the 5-FU ASMq dose groups, the levels of SOD and GSH-Px are reduced compared with that in the 5-FU control group, and the difference is significant (P<0.05). In the 5-FU medium-dose ASMq group, the SOD and GSH-Px levels are high. With respect to the MDA values, the 5-FU medium-dose ASMq group has the lowest values and in comparison with the model control group, the difference is significant (P<0.05). With respect to the SOD and GSH-Px levels, compared with the model group, the 5-FU high dose ASMq group has lower levels, and the difference is significant (P<0.05). For the synergy and the attenuation of the abnormal savda munziq combined 5-fluorouracil to the transplanted EAC tumor, abnormal savda munziq dose group, the SOD, GSHPx levels are up to close to normal. The lowest MDA values of the abnormal savda munziq dose group indicate that the combination of the abnormal savda munziq can reduce the toxicity of the 5-fluorouracil portability EAC tumor significantly.